Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 33 entries
Sorted by: Best Match Show Resources per page
Viewing photos and reading nouns of natural graspable objects similarly modulate motor responses.

Frontiers in human neuroscience

Marino BF, Sirianni M, Volta RD, Magliocco F, Silipo F, Quattrone A, Buccino G.
PMID: 25538596
Front Hum Neurosci. 2014 Dec 04;8:968. doi: 10.3389/fnhum.2014.00968. eCollection 2014.

It is well known that the observation of graspable objects recruits the same motor representations involved in their actual manipulation. Recent evidence suggests that the presentation of nouns referring to graspable objects may exert similar effects. So far, however,...

Cite
Marino BF, Sirianni M, Volta RD, et al. Viewing photos and reading nouns of natural graspable objects similarly modulate motor responses. Front Hum Neurosci. 2014;8:968doi: 10.3389/fnhum.2014.00968.
Marino, B. F., Sirianni, M., Volta, R. D., Magliocco, F., Silipo, F., Quattrone, A., & Buccino, G. (2014). Viewing photos and reading nouns of natural graspable objects similarly modulate motor responses. Frontiers in human neuroscience, 8968. https://doi.org/10.3389/fnhum.2014.00968
Marino, Barbara F M, et al. "Viewing photos and reading nouns of natural graspable objects similarly modulate motor responses." Frontiers in human neuroscience vol. 8 (2014): 968. doi: https://doi.org/10.3389/fnhum.2014.00968
Marino BF, Sirianni M, Volta RD, Magliocco F, Silipo F, Quattrone A, Buccino G. Viewing photos and reading nouns of natural graspable objects similarly modulate motor responses. Front Hum Neurosci. 2014 Dec 04;8:968. doi: 10.3389/fnhum.2014.00968. eCollection 2014. PMID: 25538596; PMCID: PMC4255516.
Copy Download .nbib Format: NLM
Can ultrasonographic findings of perihepatic lymphadenopathy promote investigations to detect possible presence of virus C infection in non-symptomatic subjects?.

Hepatology research : the official journal of the Japan Society of Hepatology

Neri S, Ierna D, Mauceri B, Abate G, Cilio D, Bordonaro F, Calvagno S, Balsamo D, Pulvirenti D, Magliocco O, Ignaccolo L, Malaguarnera M, Caruso L.
PMID: 14563426
Hepatol Res. 2003 Oct;27(2):124-128. doi: 10.1016/s1386-6346(03)00198-0.

PURPOSE: Only early detection of non-symptomatic patients is able to arrest the diffusion of the non-symptomatic HCV infection and lead to prompt treatment. Our aim was to attempt to correlate the presence of perihepatic lymph nodes and hepatitis C...

Cite
Neri S, Ierna D, Mauceri B, et al. Can ultrasonographic findings of perihepatic lymphadenopathy promote investigations to detect possible presence of virus C infection in non-symptomatic subjects?. Hepatol Res. 2003;27(2):124-128doi: 10.1016/s1386-6346(03)00198-0.
Neri, S., Ierna, D., Mauceri, B., Abate, G., Cilio, D., Bordonaro, F., Calvagno, S., Balsamo, D., Pulvirenti, D., Magliocco, O., Ignaccolo, L., Malaguarnera, M., & Caruso, L. (2003). Can ultrasonographic findings of perihepatic lymphadenopathy promote investigations to detect possible presence of virus C infection in non-symptomatic subjects?. Hepatology research : the official journal of the Japan Society of Hepatology, 27(2), 124-128. https://doi.org/10.1016/s1386-6346(03)00198-0
Neri, Sergio, et al. "Can ultrasonographic findings of perihepatic lymphadenopathy promote investigations to detect possible presence of virus C infection in non-symptomatic subjects?." Hepatology research : the official journal of the Japan Society of Hepatology vol. 27,2 (2003): 124-128. doi: https://doi.org/10.1016/s1386-6346(03)00198-0
Neri S, Ierna D, Mauceri B, Abate G, Cilio D, Bordonaro F, Calvagno S, Balsamo D, Pulvirenti D, Magliocco O, Ignaccolo L, Malaguarnera M, Caruso L. Can ultrasonographic findings of perihepatic lymphadenopathy promote investigations to detect possible presence of virus C infection in non-symptomatic subjects?. Hepatol Res. 2003 Oct;27(2):124-128. doi: 10.1016/s1386-6346(03)00198-0. PMID: 14563426.
Copy Download .nbib Format: NLM
Structure of solidified colloidal array laser filters studied by cryogenic transmission electron microscopy.

Science (New York, N.Y.)

Kamenetzky EA, Magliocco LG, Panzer HP.
PMID: 17839178
Science. 1994 Jan 14;263(5144):207-10. doi: 10.1126/science.263.5144.207.

Ordered arrays of charged uniform colloidal polystyrene particles in solution form a single-wavelength laser filter that is transparent to other wavelengths. A usable filter was prepared by solidification within an acrylamide-methylene-bisacrylamide gel. The rejection wavelength of the colloidal array...

Cite
Kamenetzky EA, Magliocco LG, Panzer HP. Structure of solidified colloidal array laser filters studied by cryogenic transmission electron microscopy. Science. 1994;263(5144):207-10doi: 10.1126/science.263.5144.207.
Kamenetzky, E. A., Magliocco, L. G., & Panzer, H. P. (1994). Structure of solidified colloidal array laser filters studied by cryogenic transmission electron microscopy. Science (New York, N.Y.), 263(5144), 207-10. https://doi.org/10.1126/science.263.5144.207
Kamenetzky, E A, et al. "Structure of solidified colloidal array laser filters studied by cryogenic transmission electron microscopy." Science (New York, N.Y.) vol. 263,5144 (1994): 207-10. doi: https://doi.org/10.1126/science.263.5144.207
Kamenetzky EA, Magliocco LG, Panzer HP. Structure of solidified colloidal array laser filters studied by cryogenic transmission electron microscopy. Science. 1994 Jan 14;263(5144):207-10. doi: 10.1126/science.263.5144.207. PMID: 17839178.
Copy Download .nbib Format: NLM
Ionic transport in crystalline SiO2: The role of alkali-metal ions and hydrogen impurities.

Physical review. B, Condensed matter

Campone P, Magliocco M, Spinolo G, Vedda A.
PMID: 9980968
Phys Rev B Condens Matter. 1995 Dec 01;52(22):15903-15908. doi: 10.1103/physrevb.52.15903.

No abstract available.

Cite
Campone P, Magliocco M, Spinolo G, et al. Ionic transport in crystalline SiO2: The role of alkali-metal ions and hydrogen impurities. Phys Rev B Condens Matter. 1995;52(22):15903-15908doi: 10.1103/physrevb.52.15903.
Campone, P., Magliocco, M., Spinolo, G., & Vedda, A. (1995). Ionic transport in crystalline SiO2: The role of alkali-metal ions and hydrogen impurities. Physical review. B, Condensed matter, 52(22), 15903-15908. https://doi.org/10.1103/physrevb.52.15903
Campone, et al. "Ionic transport in crystalline SiO2: The role of alkali-metal ions and hydrogen impurities." Physical review. B, Condensed matter vol. 52,22 (1995): 15903-15908. doi: https://doi.org/10.1103/physrevb.52.15903
Campone P, Magliocco M, Spinolo G, Vedda A. Ionic transport in crystalline SiO2: The role of alkali-metal ions and hydrogen impurities. Phys Rev B Condens Matter. 1995 Dec 01;52(22):15903-15908. doi: 10.1103/physrevb.52.15903. PMID: 9980968.
Copy Download .nbib Format: NLM
Metabolomics reveals biomarkers in human urine and plasma to predict cytochrome P450 2D6 (CYP2D6) activity.

British journal of pharmacology

Magliocco G, Desmeules J, Matthey A, Quirós-Guerrero LM, Bararpour N, Joye T, Marcourt L, Queiroz EF, Wolfender JL, Gloor Y, Thomas A, Daali Y.
PMID: 34363609
Br J Pharmacol. 2021 Dec;178(23):4708-4725. doi: 10.1111/bph.15651. Epub 2021 Sep 09.

BACKGROUND AND PURPOSE: Individualized assessment of cytochrome P450 2D6 (CYP2D6) activity is usually performed through phenotyping following administration of a probe drug to measure the enzyme's activity. To avoid any iatrogenic harm (allergic drug reaction, dosing error) related to...

Cite
Magliocco G, Desmeules J, Matthey A, et al. Metabolomics reveals biomarkers in human urine and plasma to predict cytochrome P450 2D6 (CYP2D6) activity. Br J Pharmacol. 2021;178(23):4708-4725doi: 10.1111/bph.15651.
Magliocco, G., Desmeules, J., Matthey, A., Quirós-Guerrero, L. M., Bararpour, N., Joye, T., Marcourt, L., Queiroz, E. F., Wolfender, J. L., Gloor, Y., Thomas, A., & Daali, Y. (2021). Metabolomics reveals biomarkers in human urine and plasma to predict cytochrome P450 2D6 (CYP2D6) activity. British journal of pharmacology, 178(23), 4708-4725. https://doi.org/10.1111/bph.15651
Magliocco, Gaëlle, et al. "Metabolomics reveals biomarkers in human urine and plasma to predict cytochrome P450 2D6 (CYP2D6) activity." British journal of pharmacology vol. 178,23 (2021): 4708-4725. doi: https://doi.org/10.1111/bph.15651
Magliocco G, Desmeules J, Matthey A, Quirós-Guerrero LM, Bararpour N, Joye T, Marcourt L, Queiroz EF, Wolfender JL, Gloor Y, Thomas A, Daali Y. Metabolomics reveals biomarkers in human urine and plasma to predict cytochrome P450 2D6 (CYP2D6) activity. Br J Pharmacol. 2021 Dec;178(23):4708-4725. doi: 10.1111/bph.15651. Epub 2021 Sep 09. PMID: 34363609.
Copy Download .nbib Format: NLM
Detection of cancer metastasis: past, present and future.

Clinical & experimental metastasis

Alix-Panabieres C, Magliocco A, Cortes-Hernandez LE, Eslami-S Z, Franklin D, Messina JL.
PMID: 33961169
Clin Exp Metastasis. 2021 May 07; doi: 10.1007/s10585-021-10088-w. Epub 2021 May 07.

The clinical importance of metastatic spread of cancer has been recognized for centuries, and melanoma has loomed large in historical descriptions of metastases, as well as the numerous mechanistic theories espoused. The "fatal black tumor" described by Hippocrates in...

Cite
Alix-Panabieres C, Magliocco A, Cortes-Hernandez LE, et al. Detection of cancer metastasis: past, present and future. Clin Exp Metastasis. 2021;doi: 10.1007/s10585-021-10088-w.
Alix-Panabieres, C., Magliocco, A., Cortes-Hernandez, L. E., Eslami-S, Z., Franklin, D., & Messina, J. L. (2021). Detection of cancer metastasis: past, present and future. Clinical & experimental metastasis, . https://doi.org/10.1007/s10585-021-10088-w
Alix-Panabieres, Catherine, et al. "Detection of cancer metastasis: past, present and future." Clinical & experimental metastasis vol. (2021). doi: https://doi.org/10.1007/s10585-021-10088-w
Alix-Panabieres C, Magliocco A, Cortes-Hernandez LE, Eslami-S Z, Franklin D, Messina JL. Detection of cancer metastasis: past, present and future. Clin Exp Metastasis. 2021 May 07; doi: 10.1007/s10585-021-10088-w. Epub 2021 May 07. PMID: 33961169.
Copy Download .nbib Format: NLM
Publisher Correction: ER stress-induced mediator C/EBP homologous protein thwarts effector T cell activity in tumors through T-bet repression.

Nature communications

Cao Y, Trillo-Tinoco J, Sierra RA, Anadon C, Dai W, Mohamed E, Cen L, Costich TL, Magliocco A, Marchion D, Klar R, Michel S, Jaschinski F, Reich RR, Mehrotra S, Cubillos-Ruiz JR, Munn DH, Conejo-Garcia JR, Rodriguez PC.
PMID: 31417079
Nat Commun. 2019 Aug 15;10(1):3680. doi: 10.1038/s41467-019-11563-5.

An amendment to this paper has been published and can be accessed via a link at the top of the paper.

Cite
Cao Y, Trillo-Tinoco J, Sierra RA, et al. Publisher Correction: ER stress-induced mediator C/EBP homologous protein thwarts effector T cell activity in tumors through T-bet repression. Nat Commun. 2019;10(1):3680doi: 10.1038/s41467-019-11563-5.
Cao, Y., Trillo-Tinoco, J., Sierra, R. A., Anadon, C., Dai, W., Mohamed, E., Cen, L., Costich, T. L., Magliocco, A., Marchion, D., Klar, R., Michel, S., Jaschinski, F., Reich, R. R., Mehrotra, S., Cubillos-Ruiz, J. R., Munn, D. H., Conejo-Garcia, J. R., & Rodriguez, P. C. (2019). Publisher Correction: ER stress-induced mediator C/EBP homologous protein thwarts effector T cell activity in tumors through T-bet repression. Nature communications, 10(1), 3680. https://doi.org/10.1038/s41467-019-11563-5
Cao, Yu, et al. "Publisher Correction: ER stress-induced mediator C/EBP homologous protein thwarts effector T cell activity in tumors through T-bet repression." Nature communications vol. 10,1 (2019): 3680. doi: https://doi.org/10.1038/s41467-019-11563-5
Cao Y, Trillo-Tinoco J, Sierra RA, Anadon C, Dai W, Mohamed E, Cen L, Costich TL, Magliocco A, Marchion D, Klar R, Michel S, Jaschinski F, Reich RR, Mehrotra S, Cubillos-Ruiz JR, Munn DH, Conejo-Garcia JR, Rodriguez PC. Publisher Correction: ER stress-induced mediator C/EBP homologous protein thwarts effector T cell activity in tumors through T-bet repression. Nat Commun. 2019 Aug 15;10(1):3680. doi: 10.1038/s41467-019-11563-5. PMID: 31417079; PMCID: PMC6695448.
Copy Download .nbib Format: NLM
Comparing Long-Acting Antipsychotic Discontinuation Rates Under Ordinary Clinical Circumstances: A Survival Analysis from an Observational, Pragmatic Study.

CNS drugs

Bertolini F, Ostuzzi G, Pievani M, Aguglia A, Bartoli F, Bortolaso P, Callegari C, Caroleo M, Carrà G, Corbo M, D'Agostino A, De Fazio P, Magliocco F, Martinotti G, Ostinelli EG, Piccinelli MP, Tedeschi F, Barbui C.
PMID: 33779944
CNS Drugs. 2021 Jun;35(6):655-665. doi: 10.1007/s40263-021-00809-w. Epub 2021 Mar 29.

BACKGROUND: Recent guidelines suggested a wider use of long-acting injectable antipsychotics (LAI) than previously, but naturalistic data on the consequences of LAI use in terms of discontinuation rates and associated factors are still sparse, making it hard for clinicians...

Cite
Bertolini F, Ostuzzi G, Pievani M, et al. Comparing Long-Acting Antipsychotic Discontinuation Rates Under Ordinary Clinical Circumstances: A Survival Analysis from an Observational, Pragmatic Study. CNS Drugs. 2021;35(6):655-665doi: 10.1007/s40263-021-00809-w.
Bertolini, F., Ostuzzi, G., Pievani, M., Aguglia, A., Bartoli, F., Bortolaso, P., Callegari, C., Caroleo, M., Carrà, G., Corbo, M., D'Agostino, A., De Fazio, P., Magliocco, F., Martinotti, G., Ostinelli, E. G., Piccinelli, M. P., Tedeschi, F., Barbui, C. (2021). Comparing Long-Acting Antipsychotic Discontinuation Rates Under Ordinary Clinical Circumstances: A Survival Analysis from an Observational, Pragmatic Study. CNS drugs, 35(6), 655-665. https://doi.org/10.1007/s40263-021-00809-w
Bertolini, Federico, et al. "Comparing Long-Acting Antipsychotic Discontinuation Rates Under Ordinary Clinical Circumstances: A Survival Analysis from an Observational, Pragmatic Study." CNS drugs vol. 35,6 (2021): 655-665. doi: https://doi.org/10.1007/s40263-021-00809-w
Bertolini F, Ostuzzi G, Pievani M, Aguglia A, Bartoli F, Bortolaso P, Callegari C, Caroleo M, Carrà G, Corbo M, D'Agostino A, De Fazio P, Magliocco F, Martinotti G, Ostinelli EG, Piccinelli MP, Tedeschi F, Barbui C. Comparing Long-Acting Antipsychotic Discontinuation Rates Under Ordinary Clinical Circumstances: A Survival Analysis from an Observational, Pragmatic Study. CNS Drugs. 2021 Jun;35(6):655-665. doi: 10.1007/s40263-021-00809-w. Epub 2021 Mar 29. PMID: 33779944; PMCID: PMC8219561.
Copy Download .nbib Format: NLM
Correlation of High-Risk Soft Tissue Sarcoma Biomarker Expression Patterns with Outcome following Neoadjuvant Chemoradiation.

Sarcoma

Kane JM, Magliocco A, Zhang Q, Wang D, Klimowicz A, Harris J, Simko J, DeLaney T, Kraybill W, Kirsch DG.
PMID: 29681762
Sarcoma. 2018 Feb 28;2018:8310950. doi: 10.1155/2018/8310950. eCollection 2018.

BACKGROUND: Sarcoma mortality remains high despite adjuvant chemotherapy. Biomarker predictors of treatment response and outcome could improve treatment selection.METHODS: Tissue microarrays (TMAs) were created using pre- and posttreatment tumor from two prospective trials (MGH pilot and RTOG 9514) of...

Cite
Kane JM, Magliocco A, Zhang Q, et al. Correlation of High-Risk Soft Tissue Sarcoma Biomarker Expression Patterns with Outcome following Neoadjuvant Chemoradiation. Sarcoma. 2018;2018:8310950doi: 10.1155/2018/8310950.
Kane, J. M., Magliocco, A., Zhang, Q., Wang, D., Klimowicz, A., Harris, J., Simko, J., DeLaney, T., Kraybill, W., & Kirsch, D. G. (2018). Correlation of High-Risk Soft Tissue Sarcoma Biomarker Expression Patterns with Outcome following Neoadjuvant Chemoradiation. Sarcoma, 20188310950. https://doi.org/10.1155/2018/8310950
Kane, John M, et al. "Correlation of High-Risk Soft Tissue Sarcoma Biomarker Expression Patterns with Outcome following Neoadjuvant Chemoradiation." Sarcoma vol. 2018 (2018): 8310950. doi: https://doi.org/10.1155/2018/8310950
Kane JM, Magliocco A, Zhang Q, Wang D, Klimowicz A, Harris J, Simko J, DeLaney T, Kraybill W, Kirsch DG. Correlation of High-Risk Soft Tissue Sarcoma Biomarker Expression Patterns with Outcome following Neoadjuvant Chemoradiation. Sarcoma. 2018 Feb 28;2018:8310950. doi: 10.1155/2018/8310950. eCollection 2018. PMID: 29681762; PMCID: PMC5851029.
Copy Download .nbib Format: NLM
Prophylaxis of hepatitis C with intramuscular immunoglobulin: clinical and economic appraisal.

BioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy

Piazza M, Sagliocca L, Tosone G, Guadagnino V, Stazi MA, Orlando R, Borgia G, Rosa D, Abrignani S, Palumbo F, Manzin A, Clementi M.
PMID: 18031183
BioDrugs. 1999 Oct;12(4):291-300. doi: 10.2165/00063030-199912040-00006.

Hepatitis C virus (HCV) affects millions of individuals worldwide. In most cases, HCV infection progresses to chronic liver disease and, subsequently, to liver cirrhosis and hepatocellular carcinoma. HCV is transmitted by the parenteral route, for example by transfusion of...

Cite
Piazza M, Sagliocca L, Tosone G, et al. Prophylaxis of hepatitis C with intramuscular immunoglobulin: clinical and economic appraisal. BioDrugs. 1999;12(4):291-300doi: 10.2165/00063030-199912040-00006.
Piazza, M., Sagliocca, L., Tosone, G., Guadagnino, V., Stazi, M. A., Orlando, R., Borgia, G., Rosa, D., Abrignani, S., Palumbo, F., Manzin, A., & Clementi, M. (1999). Prophylaxis of hepatitis C with intramuscular immunoglobulin: clinical and economic appraisal. BioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy, 12(4), 291-300. https://doi.org/10.2165/00063030-199912040-00006
Piazza, M, et al. "Prophylaxis of hepatitis C with intramuscular immunoglobulin: clinical and economic appraisal." BioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy vol. 12,4 (1999): 291-300. doi: https://doi.org/10.2165/00063030-199912040-00006
Piazza M, Sagliocca L, Tosone G, Guadagnino V, Stazi MA, Orlando R, Borgia G, Rosa D, Abrignani S, Palumbo F, Manzin A, Clementi M. Prophylaxis of hepatitis C with intramuscular immunoglobulin: clinical and economic appraisal. BioDrugs. 1999 Oct;12(4):291-300. doi: 10.2165/00063030-199912040-00006. PMID: 18031183.
Copy Download .nbib Format: NLM
A pilot study of radiologic measures of abdominal adiposity: weighty contributors to early pancreatic carcinogenesis worth evaluating?.

Cancer biology & medicine

Permuth JB, Choi JW, Chen DT, Jiang K, DeNicola G, Li JN, Coppola D, Centeno BA, Magliocco A, Balagurunathan Y, Merchant N, Trevino JG, Jeong D.
PMID: 28443205
Cancer Biol Med. 2017 Feb;14(1):66-73. doi: 10.20892/j.issn.2095-3941.2017.0006.

OBJECTIVE: Intra-abdominal fat is a risk factor for pancreatic cancer (PC), but little is known about its contribution to PC precursors known as intraductal papillary mucinous neoplasms (IPMNs). Our goal was to evaluate quantitative radiologic measures of abdominal/visceral obesity...

Cite
Permuth JB, Choi JW, Chen DT, et al. A pilot study of radiologic measures of abdominal adiposity: weighty contributors to early pancreatic carcinogenesis worth evaluating?. Cancer Biol Med. 2017;14(1):66-73doi: 10.20892/j.issn.2095-3941.2017.0006.
Permuth, J. B., Choi, J. W., Chen, D. T., Jiang, K., DeNicola, G., Li, J. N., Coppola, D., Centeno, B. A., Magliocco, A., Balagurunathan, Y., Merchant, N., Trevino, J. G., & Jeong, D. (2017). A pilot study of radiologic measures of abdominal adiposity: weighty contributors to early pancreatic carcinogenesis worth evaluating?. Cancer biology & medicine, 14(1), 66-73. https://doi.org/10.20892/j.issn.2095-3941.2017.0006
Permuth, Jennifer B, et al. "A pilot study of radiologic measures of abdominal adiposity: weighty contributors to early pancreatic carcinogenesis worth evaluating?." Cancer biology & medicine vol. 14,1 (2017): 66-73. doi: https://doi.org/10.20892/j.issn.2095-3941.2017.0006
Permuth JB, Choi JW, Chen DT, Jiang K, DeNicola G, Li JN, Coppola D, Centeno BA, Magliocco A, Balagurunathan Y, Merchant N, Trevino JG, Jeong D. A pilot study of radiologic measures of abdominal adiposity: weighty contributors to early pancreatic carcinogenesis worth evaluating?. Cancer Biol Med. 2017 Feb;14(1):66-73. doi: 10.20892/j.issn.2095-3941.2017.0006. PMID: 28443205; PMCID: PMC5365183.
Copy Download .nbib Format: NLM
Understanding genomics and the immune environment of penile cancer to improve therapy.

Nature reviews. Urology

Aydin AM, Chahoud J, Adashek JJ, Azizi M, Magliocco A, Ross JS, Necchi A, Spiess PE.
PMID: 32812000
Nat Rev Urol. 2020 Oct;17(10):555-570. doi: 10.1038/s41585-020-0359-z. Epub 2020 Aug 18.

The incidence of penile squamous cell carcinoma (PSCC) has increased in developed countries over the past decades owing to increased human papilloma virus (HPV) exposure. Despite successful surgical treatment of locoregional PSCC, effective treatment options for advanced disease are...

Cite
Aydin AM, Chahoud J, Adashek JJ, et al. Understanding genomics and the immune environment of penile cancer to improve therapy. Nat Rev Urol. 2020;17(10):555-570doi: 10.1038/s41585-020-0359-z.
Aydin, A. M., Chahoud, J., Adashek, J. J., Azizi, M., Magliocco, A., Ross, J. S., Necchi, A., & Spiess, P. E. (2020). Understanding genomics and the immune environment of penile cancer to improve therapy. Nature reviews. Urology, 17(10), 555-570. https://doi.org/10.1038/s41585-020-0359-z
Aydin, Ahmet Murat, et al. "Understanding genomics and the immune environment of penile cancer to improve therapy." Nature reviews. Urology vol. 17,10 (2020): 555-570. doi: https://doi.org/10.1038/s41585-020-0359-z
Aydin AM, Chahoud J, Adashek JJ, Azizi M, Magliocco A, Ross JS, Necchi A, Spiess PE. Understanding genomics and the immune environment of penile cancer to improve therapy. Nat Rev Urol. 2020 Oct;17(10):555-570. doi: 10.1038/s41585-020-0359-z. Epub 2020 Aug 18. PMID: 32812000.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 33 entries